Who Paid My Doc
Manta
Device Interventional Access
General payments
$379,416
Research payments
$630,115
Through program year 2024, $379,416 in general payments and $630,115 in research payments were reported against Manta (Interventional Access).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $108,114 | 486 |
| 2024 | Research | $455,858 | 54 |
| 2023 | General | $87,172 | 543 |
| 2023 | Research | $163,407 | 14 |
| 2022 | General | $89,641 | 725 |
| 2021 | General | $54 | 2 |
| 2020 | General | $6,341 | 159 |
| 2019 | General | $88,095 | 155 |
| 2019 | Research | $10,850 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 37 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
2,070 general · 70 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.